FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Measure

355 resources

Type: Text:

By Version

By Authority

By Realm

  • none: 193
  • us: 37
  • uv: 125

 

Rows 0 - 200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuth
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-1Bystander Chest Compressionsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-10TBDunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-2Dispatch coached chest compressionsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-3Time from PSAP to initial compressionsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-4Time to initial shockunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-5Average chest compression rateunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-6Average chest compression depthunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-7Return of Spontaneous Circulation (ROSC)during EMS careunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-8Survival of OHCA with all presenting rhythmsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-CPR-9Survival of OHCA when witnessed by bystanderunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-01Treatment Administered for Hypoglycemiaunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-02Improved Post-Treatment Conditionunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-03Hypoglycemic Patients Treated and not Transportedunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Hypoglycemia-04Repeat Response for Patient Previously Not Transportedunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-01Percentage of suspected opioid OD patients who received Narcanunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-02Percentage of suspected opioid OD patients transported to an EDunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-03Percentage of suspected opioid OD patients given multiple Narcan doses in case of an “Unchanged” response to the first doseunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-04Percentage of suspected opioid OD patients experiencing a repeat OD within a specified time period.unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-05Percentage of suspected opioid OD patients with a recorded combination of altered mental status, poor respiratory effort (RR<12 per minute), and pin point pupils.unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-06Percentage of suspected opioid OD patients with a specific opioid recordedunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-07Percentage of suspected opioid OD patients experiencing an Increase in pulse oximetry after EMS care.unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-08Percentage of suspected opioid OD patients experiencing an Increase in Glasgow Coma Scale (GCS) after EMS care.unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-09Percentage of suspected opioid OD patients experiencing an Increase in respiratory rate after EMS care.unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-10Percentage of suspected opioid OD patients who received ventilatory support within five minutes of first EMS unit’s arrival on scene.unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Opioid-11Percentage of suspected opioid OD patients experiencing who exhibit adverse effects after naloxone administrationunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-01Respiratory Assessment - Pediatricunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-02Administration of beta agonist for pediatric asthmaunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-03Documentation of estimated weight in kilograms - pediatricunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-PEDS-04Medication error rateunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-1Time to first EKGunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-2Time to receiving facility pre-notificationunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-3Transport to PCI/Thrombolytic capable facilitiesunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-4Time from First medical contact to receiving facilityunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-5Patients with complete bundle of careunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-6EMS correctly identified STEMIunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-STEMI-7Time to Reperfusionunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-01Lights and Sirens Response to Scene Rateunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-02Lights and Sirens Transport Rateunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-03Number of crashesunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-04Number of crashes resulting in injuryunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-05Number of fatal crashesunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-06Rate of crashes per 100,000miunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-07Rate of crashes resulting in injury per 100,000miunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Safety-08Rate of fatalities per 100,000miunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Seizure-01Blood Glucose Evaluationunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Seizure-02Patient Received Interventionunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Seizure-03Patients with Terminated Seizuresunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-01Suspected Stroke Receiving Prehospital Stroke Assessmentunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-02Blood Glucose Measurement for Patients with a Provider Impression of Strokeunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-03Prehospital Notificationunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-04Positive Stroke Assessments Transported to a Hospital Verified, Designated or Otherwise Identified as Acute Stroke-Ready or Higherunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-05Provider Impression of Stroke with Last Known Well (LKW) Documented unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-06Prehospital Stroke Care Bundleunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-07For Patients with Positive Stroke Assessment, Average Time from Last Known Well to Arrival at a Hospital Verified, Designated or Otherwise Identified as Acute Stroke-Ready or Higherunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Stroke-08Emergency Department Diagnosed Stroke Identified by Prehospital Stroke Assessment unknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-01Pain assessment of injured patientsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-02Pain re-assessment of injured patientsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-03Effectiveness of pain management for injured patientsunknown2024-10uvihe
ihe.qrph.qoreR4Measure/example-IHE-QORE-Trauma-04Trauma patients transported to trauma centerunknown2024-10uvihe
ihe.palm.rpcR4Measure/MeasureBreastDistanceFromTheNippleBreast Distance from the Nipple Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureBreastLateralityBreast Laterality Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureBreastLocationOfLesionBreast Location of Lesion Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureBreastQuadrantAndClockFaceBreast Quadrant and Clock Face Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureGleasonGleason Score Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureProstateLesionSizeProstate Lesion Size Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureProstateSizeProstate Size Rad Path Correlationdraft2023-06uvihe
ihe.palm.rpcR4Measure/MeasureProstateTumorLocationProstate Tumor Location Rad Path Correlationdraft2023-06uvihe
smart.who.int.hivR4Measure/HIVIND35HIV.IND.35 ARV toxicity prevalencedraft2024-08who
smart.who.int.hivR4Measure/HIVIND41HIV.IND.41 ART coverage in breastfeeding mothersdraft2024-08who
smart.who.int.hivR4Measure/HIVIND39HIV.IND.39 Infant ARV prophylaxis coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND38HIV.IND.38 Early infant diagnosis (EID) coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND42HIV.IND.42 Final outcome of PMTCTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND37HIV.IND.37 Viral suppression at labour and deliverydraft2024-08who
smart.who.int.hivR4Measure/HIVIND40HIV.IND.40 ART coverage in pregnant womendraft2024-08who
smart.who.int.hivR4Measure/HIVIND14HIV.IND.14 OAMT minimum dosedraft2024-08who
smart.who.int.hivR4Measure/HIVIND13HIV.IND.13 OAMT minimum durationdraft2024-08who
smart.who.int.hivR4Measure/HIVIND6HIV.IND.6 PEP completiondraft2024-08who
smart.who.int.hivR4Measure/HIVIND7HIV.IND.7 HIV in PEP recipientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND11HIV.IND.11 OAMT coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND76HIV.IND.76 Presence of STI syndrome, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND78HIV.IND.78 Repeat diagnosis of STI syndrome, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND70HIV.IND.70 Gonorrhoea testing coverage, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND74HIV.IND.74 Gonorrhoea treatment coverage, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND66HIV.IND.66 Syphilis treatment coverage, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND83HIV.IND.83 HCV test coverage, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND80HIV.IND.80 HBV test coverage, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND62HIV.IND.62 Syphilis test positivity, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND58HIV.IND.58 Syphilis testing coverage, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND88HIV.IND.88 HCV positivity, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND53HIV.IND.53 Multi-month ARV dispensingdraft2024-08who
smart.who.int.hivR4Measure/HIVIND92HIV.IND.92 HCV cured among people living with HIVdraft2024-08who
smart.who.int.hivR4Measure/HIVIND90HIV.IND.90 HBV treatment among people living with HIVdraft2024-08who
smart.who.int.hivR4Measure/HIVIND91HIV.IND.91 HCV treatment among people living with HIVdraft2024-08who
smart.who.int.hivR4Measure/HIVIND77HIV.IND.77 Presence of STI syndrome, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND79HIV.IND.79 Repeat diagnosis of STI syndrome, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND57HIV.IND.57 Viral suppression among people living with HIV engaged in DSD ART modelsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND55HIV.IND.55 Coverage of DSD ART models among people living with HIV on ARTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND52HIV.IND.52 TB treatment initiation among diagnoseddraft2024-08who
smart.who.int.hivR4Measure/HIVIND50HIV.IND.50 TB testing among those symptom-screened positivedraft2024-08who
smart.who.int.hivR4Measure/HIVIND51HIV.IND.51 TB diagnosis among those tested for TBdraft2024-08who
smart.who.int.hivR4Measure/HIVIND47HIV.IND.47 People living with HIV with active TB diseasedraft2024-08who
smart.who.int.hivR4Measure/HIVIND48HIV.IND.48 TB screening coverage among new ART patientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND49HIV.IND.49 TB symptom-screened positive among new ART patientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND29HIV.IND.29 People living with HIV on ART who have suppressed viral loaddraft2024-08who
smart.who.int.hivR4Measure/HIVIND32HIV.IND.32 Viral load testing coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND34HIV.IND.34 Appropriate second viral load test after adherence counsellingdraft2024-08who
smart.who.int.hivR4Measure/HIVIND71HIV.IND.71 Gonorrhoea testing coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND75HIV.IND.75 Gonorrhoea treatment coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND67HIV.IND.67 Syphilis treatment coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND31HIV.IND.31 Late ART initiationdraft2024-08who
smart.who.int.hivR4Measure/HIVIND73HIV.IND.73 Gonorrhoea test positivity, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND84HIV.IND.84 HCV test coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND81HIV.IND.81 HBV test coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND63HIV.IND.63 Syphilis test positivity, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND59HIV.IND.59 Syphilis testing coverage, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND46HIV.IND.46 TB diagnostic testing typedraft2024-08who
smart.who.int.hivR4Measure/HIVIND89HIV.IND.89 HCV positivity, HIV-positive clientsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND21HIV.IND.21 Linkage to ARTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND54HIV.IND.54 Uptake of DSD ART models among people living with HIVdraft2024-08who
smart.who.int.hivR4Measure/HIVIND3HIV.IND.3 PrEP coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND56HIV.IND.56 Retention in DSD ART modelsdraft2024-08who
smart.who.int.hivR4Measure/HIVIND25HIV.IND.25 HIV retesting coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND9HIV.IND.9 Regular NSP accessdraft2024-08who
smart.who.int.hivR4Measure/HIVIND8HIV.IND.8 NSP coveragedraft2024-08who
smart.who.int.hivR4Measure/HIVIND72HIV.IND.72 Gonorrhoea test positivity, HIV prevention servicesdraft2024-08who
smart.who.int.hivR4Measure/HIVIND12HIV.IND.12 Total person-years on OAMTdraft2024-08who
smart.who.int.hivR4Measure/HIVIND68HIV.IND.68 Syphilis treatment coverage, pregnant women, first ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND43HIV.IND.43 HIV prevalence among women attending ANCdraft2024-08who
smart.who.int.hivR4Measure/HIVIND64HIV.IND.64 Syphilis test positivity, pregnant women, first visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND65HIV.IND.65 Syphilis test positivity, pregnant women, any visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND69HIV.IND.69 Syphilis treatment coverage, pregnant women, any ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND82HIV.IND.82 HBV test coverage, pregnant womendraft2024-08who
smart.who.int.hivR4Measure/HIVIND61HIV.IND.61 Syphilis testing coverage, pregnant women, any ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND60HIV.IND.60 Syphilis testing coverage, pregnant women, first ANC visitdraft2024-08who
smart.who.int.hivR4Measure/HIVIND95HIV.IND.95 Invasive cervical cancer treatmentdraft2024-08who
smart.who.int.hivR4Measure/HIVIND94HIV.IND.94 Pre-invasive cervical disease treatmentdraft2024-08who
smart.who.int.hivR4Measure/HIVIND20HIV.IND.20 Individuals testing positive for HIVdraft2024-08who
hl7.fhir.us.davinci-deqmR4Measure/measure-mrp-exampleMRP Measureactive2019-12ushl7
hl7.fhir.uv.cqmR4Measure/measure-cqm-publishable-exampleMeasure CQM Publishable Exampleactive2025-07uvhl7
hl7.fhir.uv.cqmR4Measure/age-stratified-exampleMeasure Age Stratified Exampleactive2025-08uvhl7
smart.who.int.hivR4Measure/HIVIND24HIV.IND.24 HTS linkage to preventiondraft2024-08who
hl7.fhir.uv.cqmR4Measure/measure-pi-exmEXM Promoting Interoperability Measureactive2023-05uvhl7
hl7.fhir.uv.cqmR4Measure/EXMLogic-FHIREXM Measureactive2025-08uvhl7
hl7.fhir.us.cqfmeasuresR4Measure/EXMLogic-FHIREXM Measureactive2022-02ushl7
hl7.fhir.uv.cqmR4Measure/EXMRatio-FHIREXM Ratio Measureactive2025-08uvhl7
hl7.fhir.uv.cqmR4Measure/measure-publishable-exmEXM Publishable Measureactivecqi2025-08uvhl7
hl7.fhir.us.davinci-deqmR4Measure/measure-pi-exampleEXM Promoting Interoperability Measureactive2023-05ushl7
hl7.fhir.uv.cpgR4Measure/chf-bodyweight-change-measureCHF Body Weight Change Metricactive2024-11uvhl7
hl7.fhir.uv.cpgR4Measure/chf-bodyweight-measureCHF Body Weight Metricactive2024-11uvhl7
smart.who.int.hivR4Measure/HIVIND96HIV.IND.96 Cervical cancer survivaldraft2024-08who
example.fhir.uv.mycontentigR4Measure/HRExampleCVMeasureHR Example CV (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
example.fhir.uv.mycontentigR4Measure/HRExampleCohortMeasureHR Example Cohort (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
example.fhir.uv.mycontentigR4Measure/HRExampleProportionMeasureHR Example Proportion (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
example.fhir.uv.mycontentigR4Measure/HRExampleRatioMeasureHR Example Ratio (Measure Name in Details Tab of MADiE UI)draft2025-08uvhl7
hl7.fhir.us.davinci-vbprR4Measure/vbp-measure02Example Value-Based Contract - ABC Payer and EveryHospitalactive2025-07ushl7
hl7.fhir.us.davinci-vbprR4Measure/vbp-measure01Example Value-Based Contract - ABC Payer and GoodHealthactive2025-07ushl7
hl7.fhir.uv.cpgR4Measure/activity-example-generatereport-measureActivity Example Generate Report Measureactive2023-10uvhl7
example.fhir.uv.mycontentigR4Measure/QuestionnaireMeasureExampleQuestionnaire Measure Exampledraft2025-08uvhl7
hl7.fhir.us.davinci-raR4Measure/RAModelExample02Risk Adjustment Model Version 21 - CMS Hierarchical Category Condition (CMS-HCC)active2021-09ushl7
hl7.fhir.us.davinci-raR4Measure/RAModelExample01Risk Adjustment Model Version 24 - CMS Hierarchical Category Condition (CMS-HCC)active2021-08ushl7
hl7.fhir.us.davinci-raR4Measure/RAModelExample03Risk Adjustment Model Version 5 - CMS Prescribing Drug Hierarchical Category Condition (CMS-RxHCC)active2021-09ushl7
hl7.fhir.us.safrR4Measure/HospitalRespiratoryDataMeasureMeasure - HRD Measure Exampledraft2024-12ushl7
ihe.qrph.madxR4Measure/madx-hiv-indicator-example1mADX-Measure-example1draft2024-08uvihe
ihe.qrph.madxR4Measure/madx-hiv-indicator-example2mADX-Measure-example2draft2024-08uvihe
smart.who.int.immunizationsR4Measure/IMMZIND01IMMZIND01draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND02IMMZIND02draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND03IMMZIND03draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND04IMMZIND04draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND05IMMZIND05draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND06IMMZIND06draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND07IMMZIND07draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND08IMMZIND08draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND09IMMZIND09draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND10IMMZIND10draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND11IMMZIND11draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND12IMMZIND12draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND13IMMZIND13draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND14IMMZIND14draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND15IMMZIND15draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND16IMMZIND16draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND17IMMZIND17draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND18IMMZIND18draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND19IMMZIND19draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND20IMMZIND20draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND21IMMZIND21draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND22IMMZIND22draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND23IMMZIND23draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND24IMMZIND24draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND25IMMZIND25draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND26IMMZIND26draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND27IMMZIND27draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND28IMMZIND28draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND29IMMZIND29draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND30IMMZIND30draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND31IMMZIND31draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND32IMMZIND32draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND33IMMZIND33draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND34IMMZIND34draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND35IMMZIND35draft2025-06who
smart.who.int.immunizationsR4Measure/IMMZIND36IMMZIND36draft2025-06who